For the Inventor, By the Inventor

Enter assignee name

Bedford, MA, United States of America

Ixcela, Inc.

USPTO Granted Patents = 14

EPO Patents = 1

Trademarks = 6

Forward Citations = 19

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Wayne R Matson (10 out of 39 patents)

Samantha A Matson (6 out of 6 patents)

Erika N Ebbel-Angle (5 out of 5 patents)

4. Srikant Sarangi (5 out of 5 patents)

5. Erika N Angle (3 out of 3 patents)

6. Balmiki Ray (1 out of 1 patent)

7. Liewei Wang (1 out of 8 patents)

8. Joanna Biernacka (1 out of 1 patent)

9. Mark Frye (1 out of 1 patent)

10. Richard M Weinshilboum (1 out of 35 patents)

11. Taisei Mushiroda (1 out of 2 patents)

12. Michiaki Kubo (1 out of 3 patents)

13. Rima Kaddurah-Daouk (1 out of 29 patents)

14. Beena E Thomas (1 out of 1 patent)

15. Swati Bhasin (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 11287420 - Detection and modification of gut microbial population (2022-03-29),

2. 11287419 - Detection and modification of gut microbial population (2022-03-29),

3. 11287418 - Detection and modification of gut microbial population (2022-03-29),

4. 11287417 - Detection and modification of gut microbial population (2022-03-29),

5. 11122997 - Modulating the aryl hydrocarbon receptor system to treat major depressive disorder (2021-09-21),

6. 11041847 - Detection and modification of gut microbial population (2021-06-22),

7. 10278958 - IPA as a protective agent (2019-05-07),

8. 10220066 - Treatment of virus-based diseases of the skin (2019-03-05),

9. 10213468 - Treatment of virus-based diseases of the skin (2019-02-26),

10. 10034908 - Treatment of virus-based diseases of the skin (2018-07-31),

11. 10024842 - Methods and devices for quantitating blood samples (2018-07-17),

12. 9744155 - IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk (2017-08-29),

13. 9636325 - Indole lactic acid or a mixture of indole lactic acid and indole-3-propionic acid for treatment of Huntington's disease (2017-05-02),

14. 9603837 - IPA as a therapeutic agent and a biomarker for disease risk for Huntington's disease (2017-03-28),

IXCELA, Inc. is a company that focuses on gut microbiome research and personalized nutrition. They offer a comprehensive testing and analysis platform for microbiome health, providing insights and recommendations to optimize individual health and wellness.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#42 in Bedford, MA

#1,314 in Massachusetts

#21,615 in US

#40,934 in the World

Bedford, MA, United States of America

Ixcela, Inc.

Forward Citations = 19

15 inventors:

Wayne R Matson (10 out of 39 patents)

Samantha A Matson (6 out of 6 patents)

Erika N Ebbel-Angle (5 out of 5 patents)

4. Srikant Sarangi (5 out of 5 patents)

5. Erika N Angle (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…